Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • gsk

    Tag: gsk

    You Searched For "gsk"
    GSK to sell anti-rabies vaccines Rabipur, Encepur to Bavarian Nordic for USD 1.1 billion

    GSK to sell anti-rabies vaccines Rabipur, Encepur to Bavarian Nordic for USD 1.1 billion

    Medical Dialogues Bureau22 Oct 2019 4:30 AM GMT
    The sale of GSK's anti-rabies treatment Rabipur and Encepur, used for the prevention of tick-borne encephalitis, to the Denmark-based biotechnology...
    GSK collaborates with Lyell Immunopharma on cancer cell therapies

    GSK collaborates with Lyell Immunopharma on cancer cell therapies

    Medical Dialogues Bureau12 Oct 2019 3:45 AM GMT
    Combining GSK plc's strong cell and gene therapy programmes with Lyell's technologies may allow the joint research team to maximize the activity and...
    Amid cancer scare GSK recalls heartburn drug Zantac as precautionary measure

    Amid cancer scare GSK recalls heartburn drug Zantac as precautionary measure

    Medical Dialogues Bureau9 Oct 2019 4:00 AM GMT
    GSK is recalling all unexpired stock of Zantac from pharmacies due to possible contamination with an impurity N-nitrosodimethylamine (NDMA), the...
    ZENTEL VERSUS FENTEL: HC restrains manufacture, sale of medicine for violation of trademark

    ZENTEL VERSUS FENTEL: HC restrains manufacture, sale of medicine for violation of trademark

    Farhat Nasim6 Oct 2019 5:40 AM GMT
    New Delhi: In a relief to the pharmaceutical giant in a trademark matter, the Delhi High Court has recently restrained the manufacture or sale of...
    GSK decides to recall antacid Zinetac over safety concern

    GSK decides to recall antacid Zinetac over safety concern

    Medical Dialogues Bureau26 Sep 2019 11:24 AM GMT
    New Delhi: GlaxoSmithKline Pharmaceuticals Ltd on Wednesday announced recall of ranitidine hydrochloride tablets produced in India using API sourced...
    CDSCO warns against Cancer Causing Impurities in anti-acidity drug Ranitidine, writes to state drug controllers

    CDSCO warns against Cancer Causing Impurities in anti-acidity drug Ranitidine, writes to state drug controllers

    Farhat Nasim25 Sep 2019 7:49 AM GMT
    New Delhi: To ensure patient safety, the country's apex drug regulatory body, Central Drugs Standard Control Organisation (CDSCO) has ordered an...
    GSK fights bid to strike new Zofran preemption evidence

    GSK fights bid to strike new Zofran preemption evidence

    Medical Dialogues Bureau20 Sep 2019 3:30 AM GMT
    U.S. District Judge F. Dennis Saylor during a hearing in Boston asked why some of GSK's witnesses should be allowed to put forward new opinions to...
    GSK receives USFDA panel backing for OTC nicotine oral spray for smoking de-addiction

    GSK receives USFDA panel backing for OTC nicotine oral spray for smoking de-addiction

    Farhat Nasim19 Sep 2019 4:00 AM GMT
    Johnson & Johnson (JnJ), GSK Plc's developmental partner, sell the over-the-counter nicotine oral spray in 45 countries, excluding the United...
    Dr Reddys unveils generic version of Zyban ER tablets in US

    Dr Reddys unveils generic version of Zyban ER tablets in US

    Medical Dialogues Bureau5 Sep 2019 11:31 AM GMT
    The company has launched Bupropion hydrochloride extended-release tablets USP (SR), approved by the United States Food and Drug Administration...
    GSK Pharma sells 60 acres land in Thane to Oberoi Realty for Rs 890 crore

    GSK Pharma sells 60 acres land in Thane to Oberoi Realty for Rs 890 crore

    Medical Dialogues Bureau31 Aug 2019 7:24 AM GMT
    Mumbai: Glaxo Smith Kline Pharmaceuticals (GSK) has divested around 60 acres of its lands at Thane in favour of Oberoi Realty for nearly Rs 890 crore...
    Cracking Down on Spurious Drugs: Union Health Ministry directs States to create Intelligence Cells with CDSCO

    Cracking Down on Spurious Drugs: Union Health Ministry directs States to create Intelligence Cells with CDSCO

    Medical Dialogues Bureau30 Aug 2019 9:27 AM GMT
    These intelligence cells will work in coordination with the officers of state drug departments and the Central Drug Control Standard Organisation...
    GSK Belantamab Mafodotin shows to help blood cancer patients

    GSK Belantamab Mafodotin shows to help blood cancer patients

    Medical Dialogues Bureau26 Aug 2019 3:45 AM GMT
    Two doses of Belantamab Mafodotin helped subdue the disease in adults who had received three prior treatments for multiple myeloma, a cancer of the...
    PrevNext

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier

    This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:

    Search only trustworthy HONcode health websites:

    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2020 Minerva Medical Treatment Pvt Ltd

    © 2020 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    X